[go: up one dir, main page]

AU9034291A - Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance - Google Patents

Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance

Info

Publication number
AU9034291A
AU9034291A AU90342/91A AU9034291A AU9034291A AU 9034291 A AU9034291 A AU 9034291A AU 90342/91 A AU90342/91 A AU 90342/91A AU 9034291 A AU9034291 A AU 9034291A AU 9034291 A AU9034291 A AU 9034291A
Authority
AU
Australia
Prior art keywords
ethylamide
derivates
fragment
amide
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90342/91A
Inventor
Victor Brantl
Rudiger Pipkorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharma Bissendorf Peptide GmbH
Original Assignee
Pharma Bissendorf Peptide GmbH
Bissendorf Peptide GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Bissendorf Peptide GmbH, Bissendorf Peptide GmbH filed Critical Pharma Bissendorf Peptide GmbH
Publication of AU9034291A publication Critical patent/AU9034291A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU90342/91A 1990-12-12 1991-12-10 Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance Abandoned AU9034291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4039656 1990-12-12
DE19904039656 DE4039656A1 (en) 1990-12-12 1990-12-12 DRUGS, CONTAINING THE HUMAN PARATHORMONE FRAGMENT (1-37) IN THE FORM OF AMIDE OR ETHYLAMIDE AS AN ACTIVE AGENT

Publications (1)

Publication Number Publication Date
AU9034291A true AU9034291A (en) 1992-07-08

Family

ID=6420141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90342/91A Abandoned AU9034291A (en) 1990-12-12 1991-12-10 Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance

Country Status (3)

Country Link
AU (1) AU9034291A (en)
DE (1) DE4039656A1 (en)
WO (1) WO1992010515A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
NZ257212A (en) * 1992-09-29 1996-11-26 Inhale Therapeutic Syst Parathyroid hormone formulations comprising a biologically active n-terminal fragment of the hormone
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
TW303299B (en) * 1993-07-22 1997-04-21 Lilly Co Eli
HU218940B (en) * 1994-12-22 2001-01-29 Astra Aktiebolag Paratiroid Hormone (PHT), a pharmaceutical composition for inhalation, a method for preparing, administering an inhaler device, and an inhalation device containing it
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
EP1531855A4 (en) 2002-01-10 2009-07-22 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3935738A1 (en) * 1989-10-27 1991-05-08 Forssmann Wolf Georg DRUGS CONTAINING THE HUMAN PARATHORMONE FRAGMENT (1-37) AS AN ACTIVE AGENT

Also Published As

Publication number Publication date
WO1992010515A1 (en) 1992-06-25
DE4039656A1 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
AU7122291A (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
DK0708772T3 (en) Imidazo [4,5-c] pyridin-4-amines
AU5745290A (en) Improvements in or relating to medical ventilators
FI962154L (en) Composition for the in vivo preparation of therapeutic products
EP0950665A4 (en) Modified physiologically active proteins and medicinal compositions containing the same
AU3072989A (en) Skin treatment composition
GB2228200B (en) Insecticide treatment and compositions therefor
HU9201254D0 (en) Rapamicine-carbamates and medical preparations containing them as active agents
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
ZA941199B (en) Physiologically active compound HS-1 and process for the preparation of the same
GB2281863B (en) Improvements in relation to medical diathermy
EP0437026A3 (en) Use of tandospirone in the treatment of depression
ZA891894B (en) Composition for the treatment of osteoporosis in humans
AU3434489A (en) Skin treatment formulations
AU5565890A (en) An acaricidal composition and use thereof in disinfesting treatments
HU9500120D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
ZA944187B (en) Ipsapirone medicament formulation
AU5381890A (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
AU8838291A (en) The use of carbazones as novel active ingredients in medicaments
AU625769B2 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis- inhibiting endermic preparation containing the same compound as active ingredient
GB9218709D0 (en) Biologically active health formulation
AU4096889A (en) The use of lactam derivatives in the treatment of depression
ZA919604B (en) The use of carbozones as novel active ingredients in medicaments
GB9024640D0 (en) Therapeutic formulation
GB9024639D0 (en) Therapeutic formulation